BURDEN OF HYPERKALEMIA AND RISK FACTORS IN CHRONIC KIDNEY DISEASE AND HEART FAILURE: INSIGHTS FROM ICAREME GLOBAL REGISTRY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/981d7ae4b0f520c65848514f03064e63.pdf
BURDEN OF HYPERKALEMIA AND RISK FACTORS IN CHRONIC KIDNEY DISEASE AND HEART FAILURE: INSIGHTS FROM ICAREME GLOBAL REGISTRY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Mustafa
Arici
Carol Pollock carol.pollock@sydney.edu.au University of Sydney Kolling Institute of Medical Research Sydney Australia -
Mustafa Arici aricim@gmail.com Hacettepe University Faculty of Medicine Department of Nephrology Ankara Turkey *
Kamlesh Khunti kk22@leicester.ac.uk University of Leicester Diabetes Research Centre Leicester United Kingdom -
Chien-Ning Huang cshy049@gmail.com Chung Shan Medical University Hospital Department of Medicine Taichung Taiwan -
Rubén Silva-Tinoco ruben_ost@hotmail.com Servicios de Salud Pública de la Ciudad de México Clínica Especializada en el Manejo de la Diabetes Mexico city Mexico -
Adel El Sayed adelaelsayed@gmail.com Sohag Faculty of Medicine Internal Medicine Sohag Egypt -
Sonia Citlali Juarez Comboni sonia.juarez@astrazeneca.com AstraZeneca International Medical Affairs Dubai United Arab Emirates -
Hardik Vasnawala hardik.vasnawala@astrazeneca.com AstraZeneca International Medical Affairs Dubai United Arab Emirates -
Ahmed Hadaoui ahmed.hadaoui@astrazeneca.com AstraZeneca Algeria Medical Affairs Algiers Algeria -